10 items found in 2 pages
The OPTIC study: Patient views on optimising immunotherapy in cancer
Optimisation immunotherapy clinical trials investigate ways of reducing the intensity of immunotherapy cancer treatment. This could be beneficial for patients’ quality of life. But these trials can be challenging to run, as patients may be concerned about the impact that reducing the intensity of treatment could have on the cancer. This episode of the Trial Talk podcast focuses on the MRC Clinical Trials Unit at UCL’s OPTIC study, which explores how people with cancer feel about taking part in optimisation immunotherapy trials. Clinical Fellow Sophie Merrick discusses the main barriers that patients face and recommendations to address them. Resources: •OPTIC study page: www.mrcctu.ucl.ac.uk/studies/all-st…/refine/optic/ •OPTIC results paper: www.nature.com/articles/s41416-024-02756-x.pdf •REFINE podcast episode: on.soundcloud.com/Fe3C76csHkgCg2or5 For questions or feedback on the series, message us at mrcctu.engage@ucl.ac.uk For more information and to access the transcript: bit.ly
0
6/18/2024
QW Demo
Demo of the qw tool for helping software medical devices meet regulatory requirements
15
3/1/2024
qw - the Quality Workflow tool
qw is a tool we are developing to help software projects to meet regulatory compliance. Visit https://github.com/UCL-ARC/qw for the instructions, the code and discussion pages.
30
2/29/2024
QW Tutorial
A tutorial for using the qw "Quality Workflow" tool for software medical device projects.
20
2/14/2024
STAMPEDE (part 3): Impact and legacy with Max Parmar and Nick James
STAMPEDE is a long-running trial in advanced prostate cancer, in which nearly 12,000 men have taken part. Thanks to its multi-arm multi-stage platform design, STAMPEDE has tested many different treatments and directly led to improvements in the standard of prostate cancer care several times. This Trial Talk podcast mini-series will explore the trial’s journey from its inception in the early 2000s to the end of patient recruitment in March 2023. In the final part, Max Parmar and Nick James look back over the trial’s impact on clinical practice and platform trial design, and look forward to STAMPEDE2 and their hopes for the future of prostate cancer research. - Further information is available on the STAMPEDE study page at www.mrcctu.ac.uk For questions or feedback on the series, message us at mrcctu.engage@ucl.ac.uk For more information and to access the transcript: bit.ly/3OQWhV8 As a listener, your opinion is very valuable to us. Please help us to improve the podcast in future
6
8/23/2023
Medical Women Talking: Dame Parveen Kumar
S01E03: Professor Dame Jane Dacre talks to Professor Dame Parveen Kumar.
34
7/24/2023
Medical Women Talking: Dame Clare Marx
S01E01: Professor Dame Jane Dacre talks to Dame Clare Marx, CBE
34
7/3/2023
2008-08-04-10-44-18- A Lousy Tale of the Naked Ape - Audio
Although human DNA is 98 per cent similar to that of the chimpanzee, the infections we catch are 80 per cent different. Most are new acquisitions that we have picked up as humans spread across the world. In fact, pandemic infections like smallpox and influenza only date from the last 12,000 years or so after we formed settled farming communities and later developed large colonies known as cities. Does the history of infectious diseases help to predict future epidemics?
4
4/21/2021
12 >